Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial
2020 ◽
Vol Volume 13
◽
pp. 423-431
◽
2014 ◽
Vol 122
(06)
◽
pp. 341-349
◽